Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Nigel Farage quit Parliament today as two investigations into gifts tied to crypto stakeholders unfold, triggering re...
Developers shift from splashy amenities to intentional spaces that foster belonging, a move that also redefines how l...
Phantom’s strategic pivot toward leveraged derivatives signals a new era for Solana users. This guide unpacks what it...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
Fi is rolling out a satellite-enabled dog collar that tracks pets where cell service fails, signaling a potential shi...
Strong friendships among women go beyond looks and style. This article explores what women appreciate most in each ot...
The memory-chip rally cools as prices soften and demand slows. This report weighs Micron, SanDisk, and Applied Materi...
Pony AI reports unit-level profitability in Guangzhou but faces a long road to company-wide profits as it scales flee...
A Minnesota food vendor case highlights risks in federal child nutrition programs. Learn how the scheme worked, who’s...
As JBL gears up for its 2026 earnings season, this guide breaks down what to expect from the Q2 call, how to read the...
Worldcoin schedules a 43% reduction in daily WLD unlocks ahead of July 24, but nearly half of the supply has already ...